Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review - Wikidata - awgldk - TriplyDB

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review

http://www.wikidata.org/entity/Q33756230

about

Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways Hepatocellular carcinoma in nonalcoholic fatty liver disease mimicking benign hemangioma: two case reports and literature review Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis The changing epidemiology and aetiology of hepatocellular carcinoma from 1969 through 2013 in Alaska Native people.Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.Non-alcoholic fatty liver disease: An expanded review Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humans.Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis Molecular pathology of hepatic neoplasms: classification and clinical significance.Microbiome and cancer.Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma.Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience.Hepatocellular carcinoma: focus on different aspects of management Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature Resection of nonalcoholic steatohepatitis-associated hepatocellular carcinoma: a Western experience.Diabetes and risk of cancer.Investigation of genome instability in patients with non-alcoholic steatohepatitis.Primary hepatocellular carcinoma and metabolic syndrome: An update.Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies Non-alcoholic Fatty Liver Disease: East Versus West.Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?HCC: current surgical treatment concepts.Fatty liver disease in children--what should one do?Hepatocellular carcinoma: a comprehensive overview of surgical therapy.Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD).Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.Hard clinical outcomes in patients with NAFLD.Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.Hepatitis virus and hepatocellular carcinoma in Brazil: a report from the State of Espírito Santo.A micro-RNA expression signature for human NAFLD progression Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression.Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study.Clinical Characteristics of 130 Patients With Hepatocellular Carcinoma Followed at a Tertiary Hospital From Brazil.More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.

P2860

Q26781477-1A4A40A1-4AFA-404B-BD3B-243D01F58643 Q26783372-1F78B69B-1C0D-44E5-AE7E-6EB9EBA08A8E Q28077023-EB58B565-9AB5-4763-A506-4C97098B2CB7 Q28386598-EFE4C820-5A89-493B-B4D9-20BC7C002047 Q28607750-2D93B7A7-5BFA-4652-BF4D-99E4CC0301B1 Q30152009-1ADC0534-D214-4704-B26C-A3844AEE0A54 Q30234574-D59D9CFA-3773-4FD9-8423-0729BF490419 Q33789868-C8F07BF9-0857-4C66-9501-2EDF55AB06FC Q34205386-82F0103B-40C7-4079-90A3-348C912BB3D2 Q34255487-367A387B-CB76-4B4C-BB44-AFB910FA6640 Q34304174-8E473809-0B6E-4A2C-9EA4-7A86D88108D7 Q34323499-BE2F78E5-7C13-4F3F-80E6-820CBC8826A7 Q34560811-2F30CCDD-B32C-4C8C-BA5B-7B3F5582C7FF Q34954493-F574D028-DF64-4121-9CAC-3D314B7861FA Q35430806-CF03AF8A-ED51-4FB8-BC0D-8F1CAC04FB39 Q35479378-F3043182-D61F-4391-9E1D-880AAE013AFE Q35909487-82C3A365-D17B-4773-B148-A4556F987DBD Q35986436-D6E17C11-5793-4B96-956C-CC45060C6E3B Q36125548-2C942C77-E287-4254-B26A-3AE10BE90EAE Q36231233-2BAE5B92-961F-4176-8907-191FEA7F0D57 Q36637909-4A3742F6-B8BE-495F-8E19-71DB678A9C1D Q37118838-51EED92C-77C6-4D32-95DF-E31ABF7EF872 Q37196508-3F382C3F-A97D-4E1C-B4FE-8C5BC50FF665 Q37266376-FB0B3128-8D8E-4B11-B446-536139E853AD Q37613517-E54FF306-142C-4097-B004-E061EEE75E80 Q37932057-0AD29096-CDAB-40E2-A20E-03B8C4813B09 Q37950331-25116352-D697-4988-AF4C-E0226A7FBF19 Q37980015-7ABECDE4-D137-450B-83E2-133394C9B921 Q38020773-5DDD360C-7039-4B6F-9C23-5A31647FF642 Q38217436-64E186DF-0093-4A9A-979C-679C136B811B Q38552380-9E8E453F-B281-4D35-9EDF-48FB0DD98C18 Q39283211-3C7C1E7B-E623-4D5B-A7D5-77505BD598C5 Q40706265-52E824AA-B8E6-4065-BED7-41B6B1AF1909 Q41235262-122622C4-4339-4A6B-80F8-7DB23338E965 Q41623025-362A6046-85E5-4C38-BD77-04D38A019BFA Q41647903-06598AE2-8EA3-496E-9933-8D45D28E996D Q42204462-E652B059-0C96-479E-87F5-2BAF384449E6 Q45153118-EE42182A-2BBA-4F9F-B879-57A2CF91C19D Q47132945-3C813005-5ACA-4B6F-947D-08961981F480 Q47608704-274DFFB2-475D-42D5-AB3D-5964E4B453E8

P2860

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review

http://www.wikidata.org/entity/Q33756230

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Nonalcoholic steatohepatitis-a ...... e series and literature review

@ast

Nonalcoholic steatohepatitis-a ...... e series and literature review

@en

type

label

Nonalcoholic steatohepatitis-a ...... e series and literature review

@ast

Nonalcoholic steatohepatitis-a ...... e series and literature review

@en

prefLabel

Nonalcoholic steatohepatitis-a ...... e series and literature review

@ast

Nonalcoholic steatohepatitis-a ...... e series and literature review

@en

P1433

Q33756230-0FFAB31C-E17A-4F05-B691-94EE14DA2C2A

P1476

Q33756230-A6D7B3B4-0B56-4730-9E8D-17DCFD16187A

P2093

Q33756230-0D4FBBE5-328E-4989-8BE9-DAED8F2F74E4

Q33756230-BA3E4EA3-8692-4C74-9D71-983A63057036

P2860

Q33756230-014C50A9-58A4-4B68-9C1C-A3E96644A130

Q33756230-022A8216-E258-4B0D-9428-619084158C93

Q33756230-029D7C08-AFA1-4FB8-B346-EA827702F06B

Q33756230-02AFAC34-340B-4915-9BE8-A0005027A695

Q33756230-02B93990-EC93-4F02-ACB4-E8DB20520B11

Q33756230-1FEA0358-8A92-4AC6-9734-6C40364954AB

Q33756230-23BF7B8A-71ED-4922-976D-83577AA5541E

Q33756230-280C77E0-1F0D-4724-B9E4-A238CAA54B35

Q33756230-30A21B5F-134D-4D8E-81B6-DCE91291262C

Q33756230-451B679E-FA27-4E4E-967F-3C820ACCACA7

P304

Q33756230-45ECEBA5-094B-4E99-B28B-94257B4C0B43

P31

Q33756230-03ABB824-4EF7-413A-B870-E7AE8FFC7932

P356

Q33756230-D17D9DE3-989B-4575-BF83-542368B333BD

P407

Q33756230-7CDB8773-57B6-4BFB-A7D7-46F2024B454A

P433

Q33756230-8A02ED41-A948-4557-8D41-FF5855A94D73

P478

Q33756230-A5CCAA01-AB31-46E9-A997-9528B80716AC

P577

Q33756230-8CDFCBB3-19A1-4146-BD69-78E534EBC120

P5875

Q33756230-322C71EE-5363-4732-8B71-6E95A7272487

P698

Q33756230-EC6E2E3C-4665-4FA3-8170-2F9309039F74

P921

Q33756230-D6D1A596-F441-4790-8E73-B5F73FAEDC76

P932

Q33756230-721EBB64-B706-47C7-B55A-57B7F1DA39A0

P356

WJG.V16.I12.1436

P1433

World Journal of Gastroenterology

P1476

Nonalcoholic steatohepatitis-a ...... e series and literature review

@en

P2093

Kazuhiro Nouso

http://www.w3.org/2001/XMLSchema#string

Yoshitaka Takuma

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia

Nonalcoholic fatty liver disease

Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.

Oxyradicals and DNA damage.

Mitochondrial adaptations to obesity-related oxidant stress.

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.

The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma.

P304

1436-1441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V16.I12.1436

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50346671

http://www.w3.org/2001/XMLSchema#string

P698

20333782

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

2846247

http://www.w3.org/2001/XMLSchema#string